Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder; a new report said that plasma lyso-sphingomyelin levels can be used to not only diagnose the rare disease but also predict ...

Researchers resent a new molecule for visualizing the sphingomyelin metabolism. This offers prospects for innovative therapeutic approaches in infection research. At the end of the 19th century, the ...

Sphingomyelin is a strategic lipid widely recognized for its structural and functional properties. Within the CER-001 biomedicine, it plays a central role: It stabilizes the ApoA-I protein in its ...

Phase I study of the combination of balixafortide (CXCR4 inhibitor) and eribulin in HER2-negative metastatic breast cancer (MBC) patients (pts). This is an ASCO Meeting Abstract from the 2017 ASCO ...

New fluorescent lipids demonstrate how specialized regions in the cell membrane function, explain researchers in a new report. Researchers in Japan, India and France have found that molecules move ...

Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does ...

China Pharmaceutical University has prepared and tested sphingomyelin phosphodiesterase (SMPD1; aSMase) inhibitors potentially useful for the treatment of cancer, autoimmune disease, chronic ...

Novel trifunctional sphingomyelins (TFSM) can be used to visualise Chlamydia inclusions within infected human cells and enables the detection of native sphingomyelin derivatives in non-infectious ...

ABIONYX Pharma, (FR0012616852 – ABNX – eligible for PEA PME), a next-generation biopharmaceutical company developing innovative therapies in sepsis and critical care based on an exclusive apoA-I ...